Ground breaking cancer research finds immune system link

May 24, 2013 by Susanna Wolz

(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.

Dr Connie Jackaman, Early Career Development Fellow at the Curtin Health Innovation Research Institute (CHIRI), is leading a study focused on the capacity of the immune system in older people to deal with cancers.

The research tracked particular cells within the immune system of young and geriatric mice, finding that deterioration, caused by mimicked conditions of lung cancers, could be reduced by activating other cell types.

Dr Jackaman said that the immune system in elderly people, even those who were healthy, was skewed towards but this could be mediated by targeting 'macrophages', a cell found in the immune system.

"The most important outcome from this study was that activating these restored both age-related and tumour-induced ," Dr Jackaman said.

"That is, we could make elderly cells young again by targeting them in the right way, the outcome of which could have real implications for in the elderly."

Although this is the first research undertaken on this topic, the team are confident these findings will have a positive impact on cancer and mesothelioma treatment.

The article was published in the top journal in the field of and geriatrics, Aging Cell. To read the full research article, please visit

Explore further: Immunotherapy for elderly cancer patients finds new promise in drug combination

Related Stories

Study reveals that chemotherapy works in an unexpected way

April 4, 2013

It's generally thought that anticancer chemotherapies work like antibiotics do, by directly killing off what's harmful. But new research published online on April 4 in the Cell Press journal Immunity shows that effective ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.